Month: March 2022

Mar 17 2022

Uncategorized

Health Beat: Aristada Drug for Schizophrenia

by Clinical Editor

No Comments

More than three million people in the U.S. are living with schizophrenia, a chronic brain disorder characterized by delusions and auditory and visual hallucinations. Medications can treat symptoms, bu …

Mar 16 2022

Uncategorized

Schizophrenia, bipolar increase cardiovascular risk – Medical News Today

by Clinical Editor

No Comments

Schizophrenia, bipolar increase cardiovascular risk  Medical News Today Heart Risks Double for People With Bipolar, Schizophrenia  U.S. News & World Report Greater Lifetime Heart Risk Seen in Bipolar, Schizophrenia  Medpage Today People with...

Mar 16 2022

Uncategorized

Home care can help with the recovery of people with schizophrenia in low- income countries

by Clinical Editor

No Comments

Community-based rehabilitation can help the recovery of people with schizophrenia in low-income countries, according to new research from experts at the University of Nottingham and Addis Ababa …

Mar 16 2022

Uncategorized

Aging with Schizophrenia: What You Need to Know

by Clinical Editor

No Comments

For most people with schizophrenia, the condition spans a lifetime. Symptoms often begin in the teen years with periods of greater intensity from time to time. As you get older,...

Mar 16 2022

Uncategorized

Health Beat: Aristada Drug for Schizophrenia

by Clinical Editor

No Comments

More than three million people in the U.S. are living with schizophrenia, a chronic brain disorder characterized by delusions and auditory and visual hallucinations. Medications can treat symptoms, bu …

Mar 16 2022

Uncategorized

Reviva Pharmaceuticals Holdings, Inc. Reports Full Year 2021 Financial Results and Recent Business Highlights

by Clinical Editor

No Comments

Topline data for pivotal Phase 3 trial evaluating brilaroxazine for the treatment of schizophrenia anticipated in mid-2023 – $29.7 Million in Cash as of December 31, 2021 – CUPERTINO, Calif.,...

Mar 16 2022

Uncategorized

Identifying young people at high risk of schizophrenia with a 16-question screening tool

by Clinical Editor

No Comments

Researchers at Washington University School of Medicine in St. Louis and colleagues in Nairobi, Kenya, have shown that a screening tool developed at Washington University can help predict in about...

Mar 15 2022

Uncategorized

Real-World Insights Into Unmet Needs Among Patients With Schizophrenia – MD Magazine

by Clinical Editor

No Comments

Real-World Insights Into Unmet Needs Among Patients With Schizophrenia  MD Magazine Schizophrenia Drugs Market Worldwide Industry Analysis, Future Demand and Forecast till 2029 |Johnson and Johnson, Bristol-Myers Squibb – The Sabre  The...

Mar 15 2022

Uncategorized

Health Beat: Aristada Drug for Schizophrenia

by Clinical Editor

No Comments

More than three million people in the U.S. are living with schizophrenia, a chronic brain disorder characterized by delusions and auditory and visual hallucinations. Medications can treat symptoms, bu …

Mar 15 2022

Uncategorized

Aging with Schizophrenia: What You Need to Know

by Clinical Editor

No Comments

For most people with schizophrenia, the condition spans a lifetime. Symptoms often begin in the teen years with periods of greater intensity from time to time. As you get older,...